This opportunity is no longer accepting applications.
grant RFA-CA-24-022

SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)

The National Cancer Institute is offering additional funding for small businesses with previously funded cancer-related projects to help them move towards commercialization. This opportunity is for projects that were funded under Phase II SBIR or STTR awards from any federal agency. The goal is to encourage partnerships with third-party investors to support the costly process of bringing new p…

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that seek additional funding to support the next stage of development for cancer-relevant projects that were …

Funding Source

Agency: National Institutes of Health
Program: SBIR
Phase: Phase II

Dates

Open for Submission: April 23, 2024
Opportunity Released: April 23, 2024
Submission Deadline: August 21, 2024
Application Window Closes: August 21, 2024

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.